中国船舶租赁公布2024年度业绩：市场表现亮眼 业 绩指标再攀新高 2025年3月26日晚，中国船舶集团(香港)航运租赁有限公司(股份代号：3877.HK)宣布其截至2024年12月 31日止年度之经审核综合年度业绩。2024年全年，公司实现营业收入40.34亿港元，实现净利润21.55亿 港元，同比分别上涨11.3%及12.7%。截至2024年12月31日止，公司的平均净资产回报率为15.7%，与 2023年末持平；平均资产回报率达4.8%，较2023年末增长0.3个百分点；净资产为142.98亿港元，较 2023年末增长11.4%；资产负债比率控制在67.5%，较2023年末下降4.1个百分点。同时，公司权益持有 人应占年内溢利为21.06亿港元，同比增长10.7%；每股基本盈利为0.342港元，同比增长10.3%；董事会 宣派末期股息每股10.4港仙。 积极应对航运租赁市场竞争，经营业绩保持稳健增长趋势 年内，中国船舶租赁通过科学的租约安排、准确的时机选择及良好的成本管控，实现了较基准市场更优 的收益。截至2024年12月31日，公司共有35艘自营及合营船舶于短期及即期市场运营，覆盖油散集气四 大主流船 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性 亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致 的任何損失承擔任何責任。 二零二五年三月二十六日 於本公告日期，本公司的執行董事為唐陽剛先生 ( 總裁 ) 及徐國祥先生 ( 副董事長及副總裁 ); 本公司的非執行 董事為朱保國先生 ( 董事長 ) 、陶德勝先生 ( 副董事長 ) 、林楠棋先生及邱慶豐先生 ; 而本公司的獨立非執行 董事為白華先生、田秋生先生、黃錦華先生、羅會遠先生及崔麗婕女士。 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第 13.10B 條而刊發。 茲載列麗珠醫藥集團股份有限公司於深圳證券交易所網站刊發之《麗珠醫藥集團股份有限公司 2024 年年度報告摘要》，僅供參閱。 承董事會命 麗珠醫藥集團股份有限公司 Livzon Pharmaceutical Group Inc. * 公司秘書 劉寧 中國，珠海 * 僅供識別 1 证券代码：000513、01513 证券简称：丽珠集团、丽珠医药 公告编号：2025-018 丽珠医药集团股份有限公司 2 ...

Core Viewpoint - The company aims to enhance quality and efficiency while returning value to shareholders through its 2025 action plan, focusing on sustainable development and strategic execution in the natural gas sector [1][5]. Group 1: Business Strategy - The company focuses on its core business of natural gas sales, infrastructure operations, and engineering, while also exploring new energy technologies such as hydrogen and biomass [1]. - The company has developed a unique coal hydrogenation technology, achieving significant milestones in clean coal utilization, which positions it for large-scale promotion [2]. - The company is committed to building a comprehensive hydrogen industry chain, integrating production, storage, and application technologies [2]. Group 2: Financial Performance and Shareholder Returns - In 2024, the company reported total revenue of 135.91 billion yuan and a net profit of 4.493 billion yuan [2]. - The company plans to distribute a cash dividend of 8.1 yuan per 10 shares for the 2024 fiscal year, with a total expected payout of approximately 3.16 billion yuan, representing 70.41% of its net profit [3]. - The company completed a share buyback of 19.75 million shares, accounting for 0.6377% of its total share capital, with a total expenditure of approximately 360.18 million yuan [2]. Group 3: Investor Communication - The company engages in various investor communication activities, including performance roadshows and investor hotlines, to enhance transparency and build trust with shareholders [3][4]. - The company emphasizes the importance of long-term relationships with investors through regular updates on operational and financial performance [3]. Group 4: ESG Commitment - The company integrates ESG principles into its strategy and operations, focusing on governance, environmental management, and social responsibility [5]. - The company has achieved high ESG ratings, including MSCI AAA and a significant improvement in its S&P Global Corporate Sustainability Assessment score [6]. - The company is committed to enhancing its ESG management capabilities and attracting ESG-related investments through targeted communication and collaboration with investors [6].